Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
about
Targeting Syk in Autoimmune Rheumatic DiseasesPreclinical lupusPreclinical systemic lupus erythematosusMass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapyPre-rheumatoid arthritis and its prevention.Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Prevention of rheumatic diseases: strategies, caveats, and future directionsImmune checkpoint receptors in regulating immune reactivity in rheumatic disease.The lung may play a role in the pathogenesis of rheumatoid arthritis.Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women.Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer's Patch T Follicular Helper Cells.The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study.Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays.Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis.Lipid and Metabolic Changes in Rheumatoid Arthritis.Clinical and serological features distinguish patients with incomplete lupus classification from systemic lupus erythematosus patients and controls.Editorial: IgA Responses and Future Development of Rheumatoid Arthritis.Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome.Targeting the Preclinical Phase of Inflammatory Bowel Disease.Chronic osteomyelitis as a risk factor for development of rheumatoid arthritis: a nationwide, population-based, cohort study.Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.Biomarkers in connective tissue diseases.Genetic and environmental risk factors for rheumatoid arthritis.The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.Childhood Residential and Agricultural Pesticide Exposures in Relation to Adult Onset Rheumatoid Arthritis in Women.Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association?Editorial: Prevention of Rheumatoid Arthritis: Now Is the Time, but How to Proceed?Berberine ameliorates collagen-induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut.Rheumatoid arthritis: Autoantibodies, citrullinated histones and initiation of synovitis.Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus.Design, synthesis and evaluation of ()-3-(7-(methyl(7-pyrrolo[2,3-]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor
P2860
Q26751042-3FEEB04F-FBED-470F-A05A-C7501E400365Q26863306-6925C124-4608-4B82-9826-C959A5D128CFQ27000666-769A0E17-0428-4AD3-9E98-E585AD76A232Q28084913-2DF9FDF8-4130-432C-9BD1-ACD6CE6025B1Q33806701-99331C5A-A197-407B-BFC3-5C1564EDE570Q34604619-873B7FF4-4695-41E6-AB1D-65A90231ACB4Q34605881-5536C366-9718-4A3B-9149-100010F4A8FAQ34897654-26E814C4-4A19-4168-B921-A3F87FDA3835Q35747705-56FACC76-6F04-4812-B5D7-B8AA42B857D3Q35983908-6809B88F-DBCD-4E34-B96A-E5F4D55EE35AQ35994587-66A734F3-222B-419C-8F68-098B3E0465C0Q36166677-3E98333F-E3C1-4DC4-AADF-C2C4906A7D2CQ36176344-A6B28F01-C679-4E52-B566-8385895AA4AAQ37228064-3CA576A3-D2A2-4D77-B014-FDE167AE9490Q37538473-75E4F780-F7A0-446D-94DB-20778BDD214CQ37727141-576133FF-64C1-49C7-92B9-505D161E6A23Q38554197-EC869FB7-371D-4FEA-B07D-5C8DCAAB7728Q38766335-01255FCB-E684-4DF9-AAD8-01ECF2BE6ACDQ38849918-46A9E33D-5CA1-4FB1-9047-647D9775ED88Q38851096-A4DC9145-7E0F-491C-AD77-10B8386C946AQ40763775-AA0B0799-F348-4074-96EB-2BC9DF1DE7FDQ40767542-320042FC-0452-474F-9CB9-86DDD28D5F2BQ41096957-93EEF7D0-1CF4-41AB-84A7-53653668AA54Q41247616-74A79F9E-03D3-440A-A972-E837B24B54A7Q41692834-B020057B-BFE0-430C-B477-DE273E9E8C5EQ47314399-F962064B-EB13-4560-A6CD-75B6E60C3E2CQ47563245-5D794160-3A72-43D0-911B-C64BEF6DA989Q47656604-278F3586-2FCE-49FB-9FC8-BE23C62EE04FQ47820377-2064F07A-D62A-4531-9A1B-E2A67C678C7DQ47968875-F75F93B4-5665-4B25-8B45-53365EC36F2CQ50882987-2D9760EA-F4E2-4997-8829-A0AD4D1A0D9DQ50932207-7A1CDE89-6942-4653-BDFA-725DF45F708DQ53328443-AF4B3E97-781C-4845-A1F5-A5CDCF354E19Q55426617-528A1DD9-9681-4428-A074-DB4C829058D0Q57557905-01331BC2-A8CA-4267-92CA-BB9534CD38D7
P2860
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@ast
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@en
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@nl
type
label
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@ast
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@en
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@nl
prefLabel
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@ast
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@en
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@nl
P2860
P3181
P356
P1476
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
@en
P2093
Kevin D Deane
P2860
P2888
P304
P3181
P356
10.1038/NRRHEUM.2014.6
P407
P577
2014-02-11T00:00:00Z
P6179
1009371428